A Study of LY3473329 in Healthy Japanese Participants

NCT05038787 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3473329
DRUG: Placebo

Sponsor

Eli Lilly and Company